Page last updated: 2024-09-03

ici 200355 and phosphoramidon

ici 200355 has been researched along with phosphoramidon in 1 studies

Compound Research Comparison

Studies
(ici 200355)
Trials
(ici 200355)
Recent Studies (post-2010)
(ici 200355)
Studies
(phosphoramidon)
Trials
(phosphoramidon)
Recent Studies (post-2010) (phosphoramidon)
21007811233

Protein Interaction Comparison

ProteinTaxonomyici 200355 (IC50)phosphoramidon (IC50)
ThermolysinBacillus thermoproteolyticus0.033
NeprilysinRattus norvegicus (Norway rat)0.0578
NeprilysinOryctolagus cuniculus (rabbit)0.0028
NeprilysinHomo sapiens (human)0.0405
Angiotensin-converting enzyme Homo sapiens (human)0.615
Endothelin-converting enzyme 1Homo sapiens (human)1.0695
P2Y purinoceptor 12Homo sapiens (human)0.017

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fahy, JV; Nadel, JA; Schuster, A; Ueki, I1

Other Studies

1 other study(ies) available for ici 200355 and phosphoramidon

ArticleYear
Cystic fibrosis sputum induces a secretory response from airway gland serous cells that can be prevented by neutrophil protease inhibitors.
    The European respiratory journal, 1995, Volume: 8, Issue:1

    Topics: Adult; Animals; Cathepsin G; Cathepsins; Cattle; Cells, Cultured; Cystic Fibrosis; Exocrine Glands; Glycopeptides; Humans; Leukocyte Elastase; Oligopeptides; Pancreatic Elastase; Protease Inhibitors; Serine Endopeptidases; Sputum; Trachea

1995